Prevalence of donor-transmitted atherosclerosis-Clinical utility of intracoronary ultrasound early after heart transplantation. A single-center study

被引:0
作者
Bedanova, Helena [1 ,2 ]
Orban, Marek [1 ,2 ]
Tretina, Martin [1 ]
Tomasek, Ales [1 ]
Malik, Petr [1 ]
Fila, Petr [1 ]
Horvath, Vladimir [1 ]
Ondrasek, Jiri [1 ]
Stepanova, Radka [1 ,2 ]
Nemec, Petr [1 ,2 ]
机构
[1] Ctr Cardiovasc & Transplant Surg Brno, Pekarska 53=, Brno 65691, Czech Republic
[2] St Annes Univ, Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic
关键词
Heart transplantation; Coronary allograft vasculopathy; Donor-transmitted coronary; atherosclerosis;
D O I
10.1016/j.crvasa.2013.03.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Coronary allograft vasculopathy (CAV) is one of the main factors limiting longterm survival following orthotopic heart transplantation (HTx). Whether or not and, if so, how donor-transmitted atherosclerosis (DCA) affects the post-transplant course of the allograft recipient is still unclear. Conventional coronary angiography is a moderately accurate technique for DCA detection as it will reveal only the more gross morphological lesions. By contrast, intravascular ultrasound (IVUS) has been shown to be a much more sensitive technique for CAV and DCA detection. In our study we sought to determine the prevalence of DCA in our HTx patient population and identify main risk factors of DCA based on donor characteristics. Patients and methods: We performed a retrospective analysis of data of 119 patients (92 men, 27 women) undergoing transplantation in our center from August 2006 through September 2012, who had survived their first post-transplant month and had coronary angiography and IVUS. Results: DCA was present in 39 patients, and not documented in 80 patients. The main risk factors for DCA included donor age, cigarette smoking, and hypertension; the other parameters were not shown to be statistically significant. In-hospital mortality was low in both groups (DCA positive and DCA negative), with one patient dying in either group. One-year mortality rates post-HTx were likewise almost identical in both groups (15.4% and 15% in DCA positive and negative, respectively). Conclusion: The prevalence of DCA in our patients was 32.8%, with major risk factors for DCA including donor age, cigarette smoking, and hypertension. As age seems to be the strongest predictor, coronary angiography should be a routine examination in individuals aged over 40 years; the examination should be considered in younger individuals with a cluster of several of risk factors. The 1-year survival in this selected patient population was identical in both groups, the implication being that the diagnosis of DCA had no effect on 1-year survival post-HTx. (C) 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp. z o. o. All rights reserved.
引用
收藏
页码:E309 / E314
页数:6
相关论文
共 30 条
[21]   The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].
Sacks, FM ;
Pfeffer, MA ;
Moye, LA ;
Rouleau, JL ;
Rutherford, JD ;
Cole, TG ;
Brown, L ;
Warnica, JW ;
Arnold, JMO ;
Wun, CC ;
Davis, BR ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009
[22]  
SANDLER D, 1991, Journal of Heart and Lung Transplantation, V10, P172
[23]   Conversion to Tacrolimus and Atorvastatin in Cyclosporine-treated Heart Transplant Recipients With Dyslipidemia Refractory to Fluvastatin [J].
Skalicka, Blanka ;
Kubanek, Milos ;
Malek, Ivan ;
Vymetalova, Yevheniya ;
Hoskova, Lenka ;
Podzimkova, Mariana ;
Kautzner, Josef .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (06) :598-604
[24]   Lipid therapy in daily routine: Guidelines compatible lipid management of patients with high cardiovascular risk in clinical practice (LIMA registry) [J].
Sonntag, F. ;
Schaefer, J. R. ;
Gitt, A. K. ;
Weizel, A. ;
Jannowitz, C. ;
Karmann, B. ;
Pittrow, D. ;
Bestehorn, K. .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (40) :2047-2052
[25]  
Tuzcu EM, 2001, CIRCULATION, V103, P2705
[26]   Simvastatin reduces graft vessel disease and mortality after heart transplantation - A four-year randomized trial [J].
Wenke, K ;
Meiser, B ;
Thiery, J ;
Nagel, D ;
vonScheidt, W ;
Steinbeck, G ;
Seidel, D ;
Reichart, B .
CIRCULATION, 1997, 96 (05) :1398-1402
[27]   The topography of intimal thickening and associated remodeling pattern of early transplant coronary disease: Influence of pre-existent donor atherosclerosis [J].
Wong, CK ;
Yeung, AC .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (08) :858-864
[28]   Statin use and risks of death or fatal rejection in the heart transplant lipid registry [J].
Wu, AH ;
Ballantyne, CM ;
Short, BC ;
Torre-Amione, G ;
Young, JB ;
Ventura, HO ;
Eisen, HJ ;
Radovancevic, B ;
Rayburn, BK ;
Lake, KD ;
Yancy, CW ;
Taylor, DO ;
Mehra, MR ;
Kubo, SH ;
Fishbein, DP ;
Zhao, XQ ;
O'Brien, KD .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (03) :367-372
[29]   Impact of Donor-Transmitted Atherosclerosis on Early Cardiac Allograft Vasculopathy: New Findings by Three-Dimensional Intravascular Ultrasound Analysis [J].
Yamasaki, Masao ;
Sakurai, Ryota ;
Hirohata, Atsushi ;
Honda, Yasuhiro ;
Bonneau, Heidi N. ;
Luikart, Helen ;
Yock, Paul G. ;
Fitzgerald, Peter J. ;
Yeung, Alan C. ;
Valantine, Hannah A. ;
Fearon, William F. .
TRANSPLANTATION, 2011, 91 (12) :1406-1411
[30]   In the Era of the Universal Use of Statins Dyslipidemia's are Still Common in Heart Transplant Recipients: A Cross-Sectional Study [J].
Zakliczynski, M. ;
Boguslawska, J. ;
Wojniak, E. ;
Zakliczynska, H. ;
Ciesla, D. ;
Nozynski, J. ;
Szygula-Jurkiewicz, B. ;
Zeglen, S. ;
Zembala, M. .
TRANSPLANTATION PROCEEDINGS, 2011, 43 (08) :3071-3073